Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer
Status:
Completed
Trial end date:
2019-06-26
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using
exemestane may fight breast cancer by lowering the amount of estrogen the body makes.
PURPOSE: This phase II trial is studying how well exemestane works in treating postmenopausal
women with stage IV breast cancer.